Aiming to expand into biotechnology industry with the proprietary DNA/RNA editing technology
EditForce was established in 2015. Since then, we have put our effort on the development of PPR proteins as the novel DNA/RNA editing tools, which are to be applied in a variety of fields such as pharmaceuticals, agriculture, and biomanufacturing.
DNA/RNA editing is an expanding field of technology as it is one of the key measures in solving the global issues including health, food, and environment.
Our PPR technology, distinguished from other conventional tools, enables editing of RNA in addition to DNA. As we have reached the stage of putting it into practice, we are eager to collaborate with specialists in each academic/industrial field in need for such novel technology. Your understanding and continuous support to us would be highly appreciated.
Our PPR technology, distinguished from other conventional tools, enables editing of RNA in addition to DNA. As we have reached the stage of putting it into practice, we are eager to collaborate with specialists in each academic/industrial field in need for such novel technology. Your understanding and continuous support to us would be highly appreciated.
To start with, we focus on the field of pharmaceuticals to discover new agents with new mechanisms of action.
President and CEO
Takashi Ono, Ph.D.